CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
25.95
-0.12 (-0.46%)
Jun 27, 2025, 4:00 PM - Market closed

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
1,9782,183---
Enterprise Value
1,2911,643---
Last Close Price
25.9528.68---
PS Ratio
2987.991916.94---
PB Ratio
2.812.98---
P/TBV Ratio
2.812.98---
EV/Sales Ratio
1949.621442.48---
Debt / Equity Ratio
0.0000.000.130.38
Asset Turnover
0.000.000.000.00-
Quick Ratio
30.4234.7613.179.328.97
Current Ratio
30.9735.3013.629.549.78
Return on Equity (ROE)
-16.57%-19.18%-31.36%-42.85%-
Return on Assets (ROA)
-12.85%-15.02%-19.97%-21.34%-
Return on Capital (ROIC)
-13.18%-15.60%-21.24%-22.42%-
Earnings Yield
-5.34%-4.03%---
FCF Yield
-4.16%-3.62%---
Buyback Yield / Dilution
-1511.14%-1343.03%-15.77%-2.48%-
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q